Recombinant MANF treatment decreased HNF4α level with or without SBT induction, which may attenuate the effect of HNF4α on the mature hepatocytes and may be benefit for the transformation of mature hepatocytes into BECs or ICC cells. The gene discussed is MANF; the disease is intrahepatic cholangiocarcinoma.